Policies and Guidelines for Investigator-Initiated Clinical Trials

Updated November 20, 2013

The NIAMS is committed to improving the health of patients with rheumatic, musculoskeletal, and skin diseases by supporting investigator-initiated clinical trials that lead to better clinical outcomes. The NIAMS' goal is to identify and fund trials that are as timely and informative as possible, and which will lead to improvements in clinical practices for disease prevention, diagnosis, and treatment. To this end, NIAMS has enhanced its clinical trials program.

How to Apply for Funding for Planning and Implementing a Clinical Trial

Frequently Asked Questions

NIAMS Investigator-Initiated Clinical Trials Policies

Supporting Information

Planning and Implementation Milestones
Consultation
Letters of Request

Tools to Use Once You Find Out You Will Be Funded

Data and Safety Monitoring
Clinical Study Documents
Clinical Trials Registration
NIH and Federal Policies

For More Information

Contact a NIAMS Clinical Coordinator

Quick Links: